ORCHARD: Osimertinib plus necitumumab in patients (pts) with advanced NSCLC whose disease progressed on first-line (1L) osimertinib Meeting Abstract
| Authors: | Riess, J. W.; De Langen, J. A.; Piotrowska, Z.; Goldberg, S. B.; Goldman, J. W.; Okamoto, I.; Aix, S. P.; Teraoka, S.; Ambrose, H.; Tang, K. H.; Maidment, J.; Ruiz, B. M.; Hewson, N.; Cosaert, J.; Yu, H. A. |
| Abstract Title: | ORCHARD: Osimertinib plus necitumumab in patients (pts) with advanced NSCLC whose disease progressed on first-line (1L) osimertinib |
| Meeting Title: | ESMO Asia Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2022 Dec 2-4 |
| Meeting Location: | Singapore |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-11-01 |
| Start Page: | S1571 |
| End Page: | S1572 |
| Language: | English |
| ACCESSION: | WOS:000897943700335 |
| DOI: | 10.1016/j.annonc.2022.10.368 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 329P -- Source: Wos |
